Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -715,075 | -479,372 | -353,046 | -76,643 | -361,918 |
| Depreciation Amortization | 24,500 | 10,404 | 5,313 | 1,403 | 4,573 |
| Accounts receivable | -41,835 | -18,988 | -7,937 | -1,466 | -19,576 |
| Other Working Capital | -66,881 | -74,745 | -101,001 | -93,919 | -107,892 |
| Other Operating Activity | 342,828 | 270,033 | 231,434 | 24,392 | 96,153 |
| Operating Cash Flow | $-456,463 | $-292,668 | $-225,237 | $-146,233 | $-388,660 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 521,994 | 486,623 | 494,559 | 152,349 | -305,790 |
| PPE Investments | -59,631 | -42,374 | -32,945 | -16,263 | -61,157 |
| Net Acquisitions | -172,556 | -172,556 | -172,556 | N/A | N/A |
| Other Investing Activity | -3,082 | -2,048 | -1,454 | -855 | -3,541 |
| Investing Cash Flow | $286,725 | $269,645 | $287,604 | $135,231 | $-370,488 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 245,625 | N/A | N/A | N/A | 235,872 |
| Debt Repayment | N/A | N/A | N/A | N/A | -267,219 |
| Common Stock Issued | 401,955 | 389,925 | 384,744 | 377,563 | 563,631 |
| Other Financing Activity | -5,026 | -4,337 | -889 | 0 | -2,134 |
| Financing Cash Flow | $642,554 | $385,588 | $383,855 | $377,563 | $530,150 |
| Beginning Cash Position | 370,829 | 370,829 | 370,829 | 370,829 | 599,827 |
| End Cash Position | 843,645 | 733,394 | 817,051 | 737,390 | 370,829 |
| Net Cash Flow | $472,816 | $362,565 | $446,222 | $366,561 | $-228,998 |
| Free Cash Flow | |||||
| Operating Cash Flow | -456,463 | -292,668 | -225,237 | -146,233 | -388,660 |
| Capital Expenditure | -59,631 | -42,374 | -32,945 | -16,263 | -61,157 |
| Free Cash Flow | -516,094 | -335,042 | -258,182 | -162,496 | -449,817 |